Pharmacy groups told the Department of Health and Human Services that any action on a prescription drug rebate rule must address skyrocketing fees extracted by PBMs on behalf of plan sponsors in Medicare Part D.
President Donald Trump issued four executive orders Friday, largely focused on bringing down drug costs, which split the industry in terms of reactions.
The president and CEO of the National Association of Chain Drug Stores, Steve Anderson, penned a letter encouraging states to maintain policies that help pharmacies meet patients’ needs during the COVID-19 pandemic and in anticipation of flu season.
The INFORM Consumers Act targets organized retail crime and would shed light on certain sellers by requiring online retailers to verify high-volume sellers.
The American Pharmacists Association is urging pharmacists and technicians to tell lawmakers to authorize pharmacists as healthcare providers under Medicare Part B for COVID-19 testing and/or influenza on an emergency basis.
The National Association of Chain Drug Stores is urging Congress to remove barriers to pharmacists advancing COVID-19 testing and that prevent a clear reimbursement pathway for pharmacists.
Doug Hoey, CEO of the National Community Pharmacists Association, is urging President Trump to eliminate pharmacy DIR fees, which he said increase prescription drug costs and are bad for seniors.
